Indications & Uses
Azomid is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Shake the bottle well before each use. Place 1 drop in the affected eye(s) three times a day. This medicine can be used together with other topical eye drops to lower eye pressure, but if more than one eye drop is being used, wait at least ten minutes between each one. Pediatric Use: For pediatric patients aged 4 weeks to 5 years, the usual dose is 1 drop in the affected eye(s) 2 times a day. Geriatric Use: No overall differences in safety or effectiveness have been seen between elderly and younger patients.
Side Effects
Blurred vision and a bitter, sour or otherwise unusual taste were the side effects reported most often with Zolopt, affecting roughly 5-10% of patients. Less commonly seen (in under 1% of patients) were blepharitis, dermatitis, dry eye, a foreign body sensation in the eye, headache, eye redness, eye discharge, eye discomfort, keratitis, eye pain and itching. Also reported at this lower frequency were allergic reactions, hair loss, chest pain, conjunctivitis, dizziness, dry mouth, breathlessness, indigestion, eye fatigue, increased muscle tone, keratoconjunctivitis, crusting or a sticky feeling along the eyelid margin, nausea, sore throat, watery eyes and hives.
Cautions & Contraindications
Warnings & Precautions
Zolopt is a sulfonamide, and although it is applied topically, it is absorbed into the bloodstream. Because of this, the same kinds of adverse reactions seen with sulfonamide medicines can also occur with topical use of Zolopt. Severe sulfonamide reactions have, though rarely, proven fatal, including Stevens-Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, aplastic anemia, and other blood disorders. Sensitization can occur whenever a sulfonamide is given again, regardless of how it is administered. If signs of a serious reaction or hypersensitivity appear, Zolopt should be stopped. Since Zolopt and its metabolite are mainly cleared by the kidneys, it is not recommended for patients with renal impairment. Zolopt has not been studied in patients with hepatic impairment, so it should be used with caution in this group.
Contraindications
Contraindicated in patients known to be hypersensitive to any ingredient in this product.